What they were paid
RxSight Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $60,000 | $169,989 | $0 | $0 | $229,989 |
| FY2024 | $60,000 | $149,945 | $0 | $0 | $209,945 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RxSight, Inc. DEF 14A filed April 28, 2026, accession 0001193125-26-187240, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themAudit
The rest of the RxSight board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| J. Andy Corley | Chair of the Board | $282,489 |
| Julie B. Andrews | Independent Director | $239,989 |
| Juliet Tammenoms Bakker | Independent Director | $234,989 |
| Raymond W. Cohen | Independent Director | $305,622 |
| Robert J. Palmisano | Independent Director | $234,989 |
| Robert Warner | Independent Director | $237,489 |
| Ron Kurtz, M.D | Director | $0 |
| Shweta Singh Maniar | Independent Director | $224,989 |
| William J. Link, Ph.D | Director | $219,989 |
The full RxSight compensation record
free company briefThis page is one director within RxSight's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat